In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

“In patients with AF at low risk of stroke, anticoagulation with daily rivaroxaban does not ... of prescribing oral ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

According to NASS, the Clinical Guidelines were based on a strict analytical process which included a strength of the ...

"This finding came as a surprise, especially in light of the safety guidelines released by the FDA in 2010 and again in 2014, ...

Experts from NYU Langone Heart will present the latest advancements in cardiovascular science and clinical care at the 2024 American Heart Association's Scientific Sessions, held from November 16 to ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...

The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...

USA: A new study from the AUGUSTUS trial has provided new insights into the most effective antithrombotic strategies for ...